TheFly.com
Open Search
keyboard_arrow_down
Type symbol to search
This symbol is non-existent:
List is empty.
Search
CERE
Cerevel Therapeutics
$
()
CERE
Cerevel Therapeutics downgraded to Neutral from Overweight at JPMorgan
CERE
3/17/2023 - 07:01am
Berenberg resumes Cerevel with Hold with data readouts postponed
CERE
3/16/2023 - 07:51am
Cerevel Therapeutics resumed with a Hold at Berenberg
CERE
3/16/2023 - 06:56am
Cerevel Therapeutics to participate in a conference call with H.C. Wainwright
CERE
3/14/2023 - 10:45am
Cerevel Therapeutics to participate in a conference call with H.C. Wainwright
CERE
3/14/2023 - 04:55am
Cerevel Therapeutics to participate in a conference call with H.C. Wainwright
CERE
3/9/2023 - 12:39pm
Cerevel Therapeutics price target lowered to $26 from $28 at Mizuho
CERE
3/9/2023 - 06:38am
Cerevel Therapeutics price target lowered to $45 from $48 at H.C. Wainwright
CERE
2/23/2023 - 06:04am
Wells Fargo downgrades Cerevel on lack of catalysts until 2024
CERE
,
TVTX
,
XENE
2/22/2023 - 16:46pm
Cerevel Therapeutics downgraded to Equal Weight from Overweight at Wells Fargo
CERE
2/22/2023 - 16:42pm
Cerevel Therapeutics reports Q4 EPS (59c), consensus (64c)
CERE
2/22/2023 - 06:36am
Cerevel Therapeutics price target raised to $46 from $41 at Cantor Fitzgerald
CERE
12/20/2022 - 07:19am
Wells Fargo keeps Overweight on Cerevel after Phase 1 emraclidine trial results
CERE
12/19/2022 - 09:05am
Cerevel Therapeutics reports 'positive' results from Phase 1 emraclidine trial
CERE
12/19/2022 - 06:32am
Cerevel Therapeutics says Emraclidine data published in The Lancet
CERE
12/15/2022 - 18:31pm
dynamic_feed
Breaking News
search
Search
menu
Menu